Kraj: Izrael
Język: hebrajski
Źródło: Ministry of Health
CYTARABINE 1 G/VIAL
GENMEDIX
L01BC01
POWDER FOR SOLUTION FOR INJECTION
I.V, S.C, INTRATRACHEAL
BEN VENUE LABORATORIES INC,USA
CYTARABINE
Cytarabine in combination with other approved anticancer drugs is indicated for remission induction in acute non-lymphcytic leukemia of adults and children. It has also been found useful in the treatment of acute lymphocytic leukemia and the blast phase of chronic myelocytic leukemia. Intrathecal administration of cytarabine is indicated in the prophylaxis and treatment of meningeal leukemia.
2008-12-01